Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The prolactin release pathway encompasses the physiological and molecular mechanisms governing the synthesis, secretion, and action of prolactin. It is primarily regulated by dopamine (inhibitory) and estrogen/TRH/suckling (stimulatory). The pathway involves the prolactin receptor (PRLR) and downstream signaling cascades like JAK/STAT, MAPK, and PI3K/AKT. Dysregulation of this pathway is implicated in various diseases, including hyperprolactinemia and certain cancers.
Dopamine agonists inhibit prolactin secretion; Dopamine antagonists increase prolactin secretion; Estrogen stimulates prolactin synthesis and release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prolactin Release Pathway.